Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05180669 · ClinicalTrials.gov registry record · NA
Reward-based Technology to Improve OUD Treatment
A NA study, sponsored by Q2i.
- Terminated
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT05180669 is a NA study that was terminated before completion, run by Q2i. The registered enrollment target is 41 participants.
The verdict
NCT05180669, a NA study, was terminated before completion, sponsored by Q2i.
- TERMINATED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
Millions of people in the US misuse opioids each year. Medication assisted treatment (MAT) for opioid use disorder (OUD) is highly efficacious, but only a fraction of OUD persons access MAT, and treatment non-adherence is common and associated with poor outcomes. This project will utilize a digital mobile platform, Opioid Addiction Recovery Support with contingency management (OARSCM), to increase MAT treatment initiation and adherence among OUD patients recruited from emergency departments and inpatient acute care.
Interventions
- OTHER OARSCM Software Application
- OTHER MyMAT Software Application
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2022-11-18 |
| Est. Completion | 2025-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05180669
The ClinicalTrials.gov registry entry for NCT05180669 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Q2i, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which OARSCM Software Application is the first listed.
NCT05180669 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05180669 about?
NCT05180669 is a clinical study titled "Reward-based Technology to Improve OUD Treatment". Millions of people in the US misuse opioids each year. Medication assisted treatment (MAT) for opioid use disorder (OUD) is highly efficacious, but only a fraction of OUD persons access MAT, and treatment non-adherence is common and associated with poor outcomes. This project will utilize a digital ...
What is the current status of trial NCT05180669?
This trial is currently terminated. It is a NA study. The enrollment target is 41 participants. The study started on 2022-11-18. Estimated completion is 2025-05-31.
What interventions are being tested in trial NCT05180669?
The interventions under investigation include: OARSCM Software Application (OTHER), MyMAT Software Application (OTHER).
Who is sponsoring clinical trial NCT05180669?
This trial is sponsored by Q2i, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.